Regeneron Pharmaceuticals (NASDAQ: REGN) shares have rallied premarket today after news broke over the weekend that US President Donald Trump was treated with the company’s experimental REGN-COV2 antibody cocktail.
According to reports, Trump was given the drug alongside Remdesivir, an antiviral treatment that has reportedly helped some coronavirus patients recover quicker.
The drug is currently undergoing trials, and in Regeneron’s latest press release, they said that their findings showed REGN-COV2 “rapidly reduced viral load through day 7 in seronegative patients.”
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
According to an Oxford University Professor involved in the UK trials of the treatment, it is “very promising.”
Professor Horby, speaking to BBC Radio 4 said that around three or four hospitals in the north were already using it, while it will be sent out to “another 30 to 40 hospitals” in the UK next week.
Regeneron has teamed up with Roche to increase the global supply of the drug if it is cleared for use.
The news has seen Regeneron’s stock price surge to $597.80, up 5.84% premarket on Monday.
PEOPLE WHO READ THIS ALSO VIEWED:
